Medical Treatments in China
World-class healthcare at a fraction of Western prices. Browse 509 treatments and compare costs for international patients.
30 treatments in Cancer Care
CAR-T Cell Therapy
CAR-T细胞治疗
Chimeric Antigen Receptor T-cell (CAR-T) therapy is a revolutionary cancer immunotherapy that reprograms a patient's own immune cells to recognize and destroy cancer cells. China is a global leader in CAR-T research and clinical application, with multiple approved products and hundreds of ongoing clinical trials. Pricing in China varies significantly: $40,000-$80,000 for clinical trial access or hospital-manufactured (in-house) CAR-T products, while NMPA-approved commercial products (such as Yescarta/Relma-cel and Carteyva) cost $138,000-$180,000. Even at the commercial price, this represents major savings versus the US, where list prices for approved CAR-T products range from $370,000-$530,000. Chinese hospitals have treated thousands of patients with hematological cancers including leukemia, lymphoma, and multiple myeloma.
Proton Beam Therapy
质子束治疗
China has rapidly expanded its proton therapy capacity with multiple state-of-the-art centers in Shanghai, Shandong, and Gansu. Proton therapy delivers precise radiation to tumors while minimizing damage to surrounding healthy tissue, making it ideal for brain tumors, pediatric cancers, and tumors near critical structures. Treatment costs in China are 60-75% lower than in the US, with comparable equipment (IBA, Varian) and experienced radiation oncology teams.
Liver Cancer Treatment (TACE & Ablation)
肝癌综合治疗
China treats the largest number of liver cancer patients globally and has developed world-leading expertise in interventional oncology techniques including transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and microwave ablation. Leading hepatobiliary centers in Beijing, Shanghai, and Guangzhou offer comprehensive treatment programs combining surgery, interventional procedures, and targeted therapy at costs 60-80% lower than in the US.
Carbon Ion Therapy
碳离子治疗
China is one of the few countries with operational carbon ion therapy centers in Shanghai, Lanzhou, and Guangzhou, offering cutting-edge particle therapy for radiation-resistant tumors. The Bragg peak advantage allows precise energy deposition directly within tumors while sparing surrounding healthy tissue. Patients benefit from 60-70% cost savings compared to equivalent treatment in the US or Japan, making China a top destination for this advanced oncology treatment.
Cancer Immunotherapy (PD-1/PD-L1)
肿瘤免疫治疗
China has developed multiple PD-1 inhibitors including sintilimab (Innovent), tislelizumab (BeiGene), camrelizumab (Hengrui), and toripalimab (Junshi) at a fraction of US pricing. These domestically-developed drugs have been validated in major clinical trials and approved for lung, liver, gastric, and esophageal cancers. With 60-75% cost savings per cycle compared to pembrolizumab or nivolumab in the US, China offers world-class immunotherapy backed by extensive real-world treatment data.
HIFU Tumor Ablation
高强度聚焦超声消融
China is the global leader in High-Intensity Focused Ultrasound (HIFU) technology — Chongqing Haifu developed the world's first clinical HIFU system and Chongqing remains the global HIFU capital. This completely non-invasive treatment requires no incision and no radiation, using focused ultrasound waves to thermally destroy tumors. It is widely used for uterine fibroids, liver tumors, pancreatic cancer, and bone metastases, with over 100,000 patients treated in China.
Cryoablation & NanoKnife
冷冻消融/纳米刀
Minimally invasive tumor destruction using cryoablation (freezing) and NanoKnife irreversible electroporation (electrical pulses). Fuda Cancer Hospital in Guangzhou is a world leader having treated over 10,000 cases with these techniques. Particularly effective for inoperable liver, lung, pancreatic, and kidney cancers where conventional surgery is not feasible. China's high-volume centers offer extensive experience at 60-75% less than US pricing.
Esophageal Cancer Surgery
食管癌手术
China has the highest esophageal cancer incidence globally, giving its thoracic surgeons unmatched operative experience — some having performed over 1,000 esophagectomies individually. Minimally invasive esophagectomy (MIE) is widely performed at leading centers including Cancer Hospital Chinese Academy of Medical Sciences, Shanghai Chest Hospital, and Henan Cancer Hospital. Patients benefit from 70-80% cost savings and access to the world's most experienced surgical teams for this specific cancer.
Lung Cancer Treatment (NSCLC)
肺癌治疗
China is a global leader in lung cancer treatment, offering cutting-edge approaches including robotic-assisted minimally invasive surgery, targeted therapy (EGFR/ALK inhibitors), immunotherapy, and advanced radiation techniques. Chinese thoracic surgeons perform some of the highest volumes of lung cancer operations worldwide, resulting in exceptional outcomes. Treatment costs are 70-80% lower than in the US, including access to novel domestic immunotherapy drugs.
Breast Cancer Treatment
乳腺癌治疗
China's breast cancer centers offer comprehensive treatment including breast-conserving surgery, mastectomy with immediate reconstruction, sentinel node biopsy, chemotherapy, hormone therapy, and HER2-targeted therapy. Leading hospitals achieve outcomes comparable to international standards with multidisciplinary tumor boards guiding each case. Patients benefit from access to both global standard drugs and domestically developed biosimilars at dramatically lower costs.
Colorectal Cancer Surgery
结直肠癌手术
Chinese colorectal surgeons perform high-volume laparoscopic and robotic resections for colon and rectal cancers with outcomes matching top international centers. Advanced techniques include total mesorectal excision (TME) for rectal cancer and minimally invasive approaches that reduce recovery time. Comprehensive care includes neoadjuvant chemoradiation when needed, all at 60-75% less than US costs.
Gastric Cancer Treatment
胃癌治疗
China has among the world's highest gastric cancer incidence, resulting in unparalleled surgical expertise and treatment protocols. Chinese surgeons routinely perform D2 lymphadenectomy — the gold standard for gastric cancer — with lower complication rates than many Western centers due to sheer volume. Patients access comprehensive care including endoscopic early-stage treatment, laparoscopic gastrectomy, perioperative chemotherapy, and novel immunotherapy combinations.
Not sure which treatment is right for you?
Our AI assistant can help you explore options and answer your questions.